EUVIMEDEUVIMED entdecken
Open Access

Inhibition of HDAC6 alleviates cancer‑induced bone pain by reducing the activation of NLRP3 inflammasome

Yin-Di Hu, Zhao-Di Wang, Yuan-Fen Yue, Dai Li, Shu-Qing Zhen, Jie-Qiong Ding, Wei Meng, Hai-Li Zhu, Min Xie, Ling Liu

International Journal of Molecular Medicine · 17.11.2023 · 53 (1)

DOI: 10.3892/ijmm.2023.5328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 17.11.2023. Verfasst von Yin-Di Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hubei University of Science and Technology, Xianning, Hubei 437100, P.R. China. Hauptthemen laut MEDLINE: Chronic Pain, Cancer Pain, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainCancer PainNeoplasmsHumansRatsMaleAnimalsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinRats, Sprague-DawleyHistone Deacetylase 6Neuroinflammatory DiseasesQuality of LifeCytokinesSpinal Cord

Stichwörter der Autor:innen

NOD‑like receptor pyrin domain containing 3 inflammasomecancer induced bone painhistone deacetylase 6neuroinflammation

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinHistone Deacetylase 6CytokinesHDAC6 protein, humanHDAC6 protein, rat

Autor:innen und Institutionen

  • School of Pharmacy, Hubei University of Science and Technology, Xianning, Hubei 437100, P.R. China.
  • Xianning Central Hospital, First Affiliated Hospital of Hubei University of Science and Technology, Xianning, Hubei 437199, P.R. China.
  • Hubei Key Laboratory of Diabetes and Angiopathy, School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei 437100, P.R. China.
  • Matang Hospital of Traditional Chinese Medicine, Xianning, Hubei 437000, P.R. China.

Zitieren

APA

Hu, Y. D., Wang, Z. D., Yue, Y. F., Li, D., Zhen, S. Q., Ding, J. Q., Meng, W., Zhu, H. L., Xie, M., & Liu, L. (2023). Inhibition of HDAC6 alleviates cancer‑induced bone pain by reducing the activation of NLRP3 inflammasome. International Journal of Molecular Medicine, 53(1). https://doi.org/10.3892/ijmm.2023.5328

Vancouver

Hu YD, Wang ZD, Yue YF, Li D, Zhen SQ, Ding JQ, et al. Inhibition of HDAC6 alleviates cancer‑induced bone pain by reducing the activation of NLRP3 inflammasome. International Journal of Molecular Medicine. 2023;53(1). doi:10.3892/ijmm.2023.5328

BibTeX
@article{Hu2023,
  author = {Hu, Yin-Di and Wang, Zhao-Di and Yue, Yuan-Fen and Li, Dai and Zhen, Shu-Qing and Ding, Jie-Qiong and Meng, Wei and Zhu, Hai-Li and Xie, Min and Liu, Ling},
  title = {Inhibition of HDAC6 alleviates cancer‑induced bone pain by reducing the activation of NLRP3 inflammasome},
  journal = {International Journal of Molecular Medicine},
  year = {2023},
  volume = {53},
  number = {1},
  doi = {10.3892/ijmm.2023.5328}
}
Kostenlos starten →